PMID: 9193292Jun 7, 1997Paper

Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease

BMJ : British Medical Journal
S Ebrahim, G D Smith

Abstract

To assess the effectiveness of multiple risk factor intervention in reducing cardiovascular risk factors, total mortality, and mortality from coronary heart disease among adults. Systematic review and meta-analysis of randomised controlled trials in workforces and in primary care in which subjects were randomly allocated to more than one of six interventions (stopping smoking, exercise, dietary advice, weight control, antihypertensive drugs, and cholesterol lowering drugs) and followed up for at least six months. Adults aged 17-73 years, 903000 person years of observation were included in nine trials with clinical event outcomes and 303000 person years in five trials with risk factor outcomes alone. Changes in systolic and diastolic blood pressure, smoking rates, blood cholesterol concentrations, total mortality, and mortality from coronary heart disease. Net decreases in systolic and diastolic blood pressure, smoking prevalence, and blood cholesterol were 4.2 mm Hg (SE 0.19 mm Hg), 2.7 mm Hg (0.09 mm Hg), 4.2% (0.3%), and 0.14 mmol/l (0.01 mmol/l) respectively. In the nine trials with clinical event end points the pooled odds ratios for total and coronary heart disease mortality were 0.97 (95% confidence interval 0.92 to 1.02)...Continue Reading

Citations

Oct 11, 2001·Arthritis and Rheumatism·N M Hadler
May 9, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·T PekkarinenM Välimäki
Nov 28, 2009·European Journal of Applied Physiology·Dick H J ThijssenDaniel J Green
Oct 3, 2008·Cardiovascular Drugs and Therapy·Eric BruckertUNKNOWN PEGASE group
May 17, 2008·Journal of Immigrant and Minority Health·Fatima El FakiriArno W Hoes
Feb 1, 2008·Journal of General Internal Medicine·Arnaud ChioleroRoger Darioli
Aug 16, 2003·Progress in Cardiovascular Diseases·James Lightwood
Jun 8, 2001·Trends in Pharmacological Sciences·S C Berry
Jul 19, 2001·Social Science & Medicine·P HeslopC Hart
Aug 2, 2001·Patient Education and Counseling·H CooperG Gill
Jun 24, 2004·Patient Education and Counseling·Janneke HartingNanne K de Vries
Sep 10, 1998·Patient Education and Counseling·S ErikssonL O Bygren
Apr 18, 2001·American Journal of Preventive Medicine·UNKNOWN US Preventive Services Task Force
Aug 28, 1999·Journal of Clinical Epidemiology·A J DobsonK D'Este
Sep 16, 2004·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·James O ProchaskaBrett A Plummer
Jan 12, 2002·Kidney International·Bertram L Kasiske
Jun 7, 2006·Scandinavian Journal of Public Health·Janus L ThomsenMarianne Engberg
Feb 16, 2012·European Heart Journal·Andrew Mente, Salim Yusuf
Jul 22, 2004·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Charles J Epstein
Jan 14, 2000·BMJ : British Medical Journal·S EbrahimR Bennett
Apr 3, 2001·BMJ : British Medical Journal·L HooperS Ebrahim
Dec 21, 2002·BMJ : British Medical Journal·James Le Fanu
Jun 18, 2005·BMJ : British Medical Journal·Peter ElwoodJanet Pickering
Jan 13, 1998·Journal of Epidemiology and Community Health·S Ebrahim
Aug 10, 2000·Occupational and Environmental Medicine·H Brenner, W Ahern
Mar 15, 2006·Annual Review of Public Health·Ihab HajjarTheodore A Kotchen
Jan 28, 2006·Hormone Research·David J P Barker
Jul 29, 2008·BMC Cardiovascular Disorders·Gill RichardsonMererid Bowley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.